BLTE Belite Bio Inc
$164.36
$5.61
(3.30%)
Closed $164.36
$0.00
(0.00%)
After Hours
Reported EarningsNov 12
Mkt Cap$6.62B
Vol216,976.00
About BLTE
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Fundamentals
51
Neutral Sentiment
How do you feel about BLTE?
Advertisement|Remove ads.
StocktwitsPolls21
70StocktwitsPolls126
208StocktwitsPolls137
204Advertisement|Remove ads.